- Home
- CTOR vs ALTS Comparison
CTOR vs ALTS Comparison
Compare CTOR & ALTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTOR
- ALTS
- Stock Information
- Founded
- CTOR 2021
- ALTS 1976
- Country
- CTOR United States
- ALTS United States
- Employees
- CTOR N/A
- ALTS N/A
- Industry
- CTOR
- ALTS
- Sector
- CTOR
- ALTS
- Exchange
- CTOR NYSE
- ALTS NYSE
- Market Cap
- CTOR 63.7M
- ALTS 159.4M
- IPO Year
- CTOR N/A
- ALTS N/A
- Fundamental
- Price
- CTOR $4.29
- ALTS $7.45
- Analyst Decision
- CTOR Buy
- ALTS
- Analyst Count
- CTOR 2
- ALTS 0
- Target Price
- CTOR $6.00
- ALTS N/A
- AVG Volume (30 Days)
- CTOR 3.1M
- ALTS 268.1K
- Earning Date
- CTOR 08-11-2025
- ALTS 08-18-2025
- Dividend Yield
- CTOR N/A
- ALTS N/A
- EPS Growth
- CTOR N/A
- ALTS N/A
- EPS
- CTOR N/A
- ALTS N/A
- Revenue
- CTOR N/A
- ALTS $18,046,000.00
- Revenue This Year
- CTOR N/A
- ALTS $185.91
- Revenue Next Year
- CTOR N/A
- ALTS $64.93
- P/E Ratio
- CTOR N/A
- ALTS N/A
- Revenue Growth
- CTOR N/A
- ALTS N/A
- 52 Week Low
- CTOR $0.55
- ALTS $1.29
- 52 Week High
- CTOR $49.00
- ALTS $10.95
- Technical
- Relative Strength Index (RSI)
- CTOR N/A
- ALTS 49.21
- Support Level
- CTOR N/A
- ALTS $8.90
- Resistance Level
- CTOR N/A
- ALTS $10.38
- Average True Range (ATR)
- CTOR 0.00
- ALTS 1.05
- MACD
- CTOR 0.00
- ALTS -0.21
- Stochastic Oscillator
- CTOR 0.00
- ALTS 19.35
About CTOR CITIUS ONCOLOGY INC
Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.
About ALTS ALT5 SIGMA CORPORATION
ALT5 Sigma Corp is a fintech company. The company operates in three operating segments: Fintech: provides next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment, and safe-keeping of digital assets, Biotechnology: Biotechnology segment is focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties; Corporate and Others: Corporate and Other segment consists of certain corporate general and administrative costs. Company has revenue from Fintech Segment.